DO DOCS Doximity, Inc. Loading... : Bullish and Bearish Analyst Opinions

Comcast plans to spin off NBCUniversal and Sky assets, while Charter and SPCX discuss a mobile partnership and Palantir delivers an AI platform with Nvidia.

Premarket movers include Magnificent Seven stocks all higher, Comcast up 22% on spin-off plans, Doximity down 4% on BofA downgrade, Iridium up 20% on Rocket Lab acquisition, Martin Marietta down 3% on deal, and Viridian up 14% on FDA approval.

Doximity shares fell 23.3% to a record low after a cautious FY26 revenue outlook trailing consensus, with rising AI costs compressing margins and a Quant Rating of Hold.

Bearish view on these names as structurally declining assets akin to linear TV; cheapness is a value trap with persistent selling pressure and zero terminal value.

Bearish view on $DOCS as competitor EvidenceOpen is disrupting the industry within two years of launch, rapidly gaining market share.

Doximity stock has crashed, but fundamentals remain robust: 20% revenue growth, rising EPS, and P/E around 20x. It operates a "sticky" platform for medical professionals (the "LinkedIn for Doctors"). The crash is a technical "falling knife" into a long-term accumulation zone. The business model is not broken, making this a value entry point. LONG. A long-term compounder currently on sale. Catching a falling knife; volatility remains high.